Sale of Bio-Pharma Firm Agalimmune Puts Discovery Park in Driving Seat for Immunotherapy and Immuno-Oncology Research
Pioneering research underway at Discovery Park in Sandwich, Kent into the treatment of cancer and other life-threatening diseases has been given a major boost following the sale of Agalimmune to the Israel-based biotech, BioLineRx Ltd.
The acquisition of Agalimmune, in a multi-million-pound cash and shares deal, represents the first UK investment for the Tel-Aviv based company, giving it access to promising technology for oncology and immuno-oncology.
Agalimmune is one of a cluster of companies at Discovery Park working on drug discovery and development.
SETsquared will be announcing its exclusive list of top 50 entrepreneurs at a reception at the House of Commons on Wednesday (29 March).
The top 50 entrepreneurs to be honoured have all reached milestone achievements, such as successfully raising a significant amount of investment, exporting products globally, had considerable societal impact, or achieved a world first.
Lloyds Bank, who supported the enabling of Boxworks at Engine Shed, which was opened on 2 December 2015, is continuing its sponsorship for the re-imagined shipping container development for another year.
Bristol City Council (BCC) granted planning permission for the development on 9 June 2015 in the Temple Quarter Enterprise Zone.
For the second year running, Exeter has been highlighted in the Tech Nation report as a thriving cluster within the UK’s digital landscape.
The latest report confirms London’s position as an international powerhouse, and the UK as the leading European country in the digital sector and possessing unrivalled digital tech specialisms.
Plusvital (www.plusvital.com), the Irish equine science company, today announced a new partne
Imperial College London ThinkSpace has signed an agreement with award-winning workspace provider Central Working to create the company’s first university-linked shared workspace in London, Central Working White City.
The Board of Exeter Science Park has announced the appointment of Dr Sally Basker as its new Chief Executive Officer (CEO). Dr Basker will take up the new role on 3rd April.
Dr Basker is a qualified engineer with 15 year’s senior level research and innovation experience in the aerospace, defence, energy and navigation sectors over her 25-year career.
Leading Life Sciences sector specialist joins award winning R&D property advisors, Creative Places, to support the innovation and commercialisation agenda of university, science park and biomedical campus clients.
Creative Places is delighted to welcome Nykki Rogers as Head of Life Sciences who has over 15 years of commercial experience in the Life Sciences sector. Her most recent roles have included leading and managing the national inward investment delivery team for Life Sciences on behalf of the Department for International Trade in
16 entrepreneurs were given the platform to realise their ambitions by exhibiting and pitching for significant investment to develop their innovative ideas and push them out to a wider market.
A CENTRE which helps North East businesses tap into the billion pound space sector has won an extension to its programme after successfully supporting new businesses and job creation.